|
|
|
| Wockhardt sells its German subsidiary | 18-JUN-09 |
|
| Debt-ridden Wockhardt Ltd today said it had sold its German subsidiary Esparma to Mova GmbH, a subsidiary of German drug major Lindopharm. Although the company did not disclose the deal size, sources said it was worth Rs 120 crore. |
|
|
|
|
|
|
| Wockhardt seeks to sell animal healthcare biz | 07-MAY-09 |
|
| Wockhardt Ltd, India’s sixth-largest drug maker, currently negotiating its debt load with banks,yesterday sought shareholders’ approval to sell its animal healthcare business for an anticipated Rs 150 crore. |
|
|
|
|
|
|
| 3 pharma majors eye Wockhardt's Irish unit | 08-APR-09 |
|
| Three leading international pharma companies have started due diligence to acquire Wockhardt Ltd’s wholly-owned Irish generic drug company, Pinewood. The company, which has given Swiss bank UBS the mandate for the sale, has been valued at Rs 1,000 crore. |
|
|
|
| Wockhardt pays $265 mn for French buy | 04-MAY-07 |
|
| In the third-largest overseas acquisition by an Indian pharmaceutical company, Mumbai-based Wockhardt Ltd has announced that it is buying the entire equity of Paris-based Negma Laboratories for $265 |
|
|
|
|
|
|
| Wockhardt closes in on Irish major | 13-SEP-06 |
|
| Wockhardt Ltd is set to sign an agreement to acquire Pinewood Laboratories of Ireland. The deal, which is expected to be in the range of Rs 500-600 crore, would make Wockhardt a strong player in |
|
|
|
| Wockhardt launches Biovac A vaccine | 08-DEC-05 |
|
| Wockhardt Ltd launched a new generation live attenuated Hepatitis A vaccine Biovac A across the country. Of the five Hepatitis vaccines currently available in the world, Biovac A is the only live |
|
|
|
| Wockhardt gets USFDA nod for antibiotic | 06-AUG-05 |
|
| Pharmaceutical and biotechnology major Wockhardt Ltd has received approval from the United States Food & Drug Administration for marketing cefuroxime axetil in the US.
|
|
|
|
| Wockhardt Q1 net dips to Rs 38 crore | 21-APR-05 |
|
| Wockhardt Ltd has recorded a 7 per cent decline in net profit at Rs 38 crore for the first quarter ended March 31, 2005, compared with Rs 41.1 crore in the same quarter of previous year.
|
|
|
|
|
|
|
|
|
|
|
|
|
Content Guide
